Skip to content

Author

G. Agrotis

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial

MRI is increasingly used to assess treatment response in muscle-invasive bladder cancer (MIBC), but only qualitatively. This study evaluates the reproducibility and predictive value of quantitative apparent diffusion coefficient (ADC), thought to be a non-invasive surrogate for tumor cell density, in patients with MIBC...

J. Greidanus, Carlotta Bernabei, K. Chupetvloska et al. · 0 citations
Review Open access Jan 2026

Prostate imaging scoring systems: indications, interpretation, and clinical impact

Abstract Prostate imaging, and especially multiparametric magnetic resonance imaging (mpMRI), has become central to the diagnosis, risk stratification, treatment planning, and follow-up of prostate cancer. Its widespread adoption has driven the development of structured imaging scoring systems designed to standardize a...

E. Messina, Antonella Borrelli, Georgios Agrotis et al. · 0 citations
Open access Oct 2026

Critical appraisal of artificial intelligence studies for prostate cancer detection on MRI.

The application of artificial intelligence (AI) to prostate MRI for clinically significant prostate cancer (csPCa) detection is an active area of medical imaging research. Yet, methodological deficiencies can undermine the reliability and clinical translatability of many published studies. This perspective provides a s...

Eduardo H. P. Pooch, Georgios Agrotis, Ivo G. Schoots et al. · 0 citations
#explainable ai Open access Sep 2026

Current status and future directions of AI in prostate cancer detection on MRI: a special report from the ESUR prostate MRI working group authors.

The gap between AI's research promise and clinical readiness is highlighted, which underscores the need for localvalidation, post-market surveillance, and adequate user training as AI tools become incorporated into diagnostic prostate MRI workflows.

Renato Cuocolo, A. Ponsiglione, G. Agrotis et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.